Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
Holders of 5% or more of AMAM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ambrx Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Ambrx Biopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Ambrx Biopharma, Inc., newest first.
No Schedule 13D or 13G filings on Ambrx Biopharma, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ambrx Biopharma, Inc. shares.
No Form 144 notices for Ambrx Biopharma, Inc. are on file.